Kanamori and colleagues suggested that fludarabine/busulfan was superior to fludarabine/melphalan although their results did not reach statistical significance [ 19 ].
← all excerpts
Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT.
1
—
—